Two doses of HPV-16/18 AS04-adjuvanted vaccine Cervarix are not inferior to three doses in the current schedule, a new study found. Since high coverage and compliance rates can be difficult to achieve with the current three-dose HPV vaccineregimen, several studies have looked at the possibility of reducing the number of doses. Proof-of-principle that a two-dose schedule can provide sufficient protection against cervical cancer came initially from a study performed ...Saturday, 29 March 2014
Safety and Immunogenicity of 2 Doses of HPV-16/18 AS04 Adjuvanted Vaccine Revealed
Two doses of HPV-16/18 AS04-adjuvanted vaccine Cervarix are not inferior to three doses in the current schedule, a new study found. Since high coverage and compliance rates can be difficult to achieve with the current three-dose HPV vaccineregimen, several studies have looked at the possibility of reducing the number of doses. Proof-of-principle that a two-dose schedule can provide sufficient protection against cervical cancer came initially from a study performed ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment